177 related articles for article (PubMed ID: 36473617)
21. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
Zhu F; Jiang Y; Luo F; Li P
J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
[TBL] [Abstract][Full Text] [Related]
22. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
[TBL] [Abstract][Full Text] [Related]
23. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y
Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin.
Liu J; Zhang Q; Wang C; Yang J; Yang S; Wang T; Wang B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108785
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound-Targeted Microbubble Destruction Enhances the Antitumor Efficacy of Doxorubicin in a Mouse Hepatocellular Carcinoma Model.
Wu Y; Sun T; Tang J; Liu Y; Li F
Ultrasound Med Biol; 2020 Mar; 46(3):679-689. PubMed ID: 31882167
[TBL] [Abstract][Full Text] [Related]
26. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
[TBL] [Abstract][Full Text] [Related]
27. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
[TBL] [Abstract][Full Text] [Related]
28. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Chem Biol Interact; 2018 Jan; 279():84-94. PubMed ID: 29133031
[TBL] [Abstract][Full Text] [Related]
30. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis.
Li W; Tian YH; Liu Y; Wang Z; Tang S; Zhang J; Wang YP
J Toxicol Sci; 2016; 41(3):417-28. PubMed ID: 27193733
[TBL] [Abstract][Full Text] [Related]
31. Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma.
Bashir AO; El-Mesery ME; Anwer R; Eissa LA
Life Sci; 2020 Aug; 254():117794. PubMed ID: 32422307
[TBL] [Abstract][Full Text] [Related]
32. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma.
Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL
Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548
[TBL] [Abstract][Full Text] [Related]
33. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
[TBL] [Abstract][Full Text] [Related]
34. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
35. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
Rai G; Mishra S; Suman S; Shukla Y
Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
[TBL] [Abstract][Full Text] [Related]
37. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway.
Hajra S; Patra AR; Basu A; Saha P; Bhattacharya S
Chem Biol Interact; 2018 Jun; 290():19-36. PubMed ID: 29775573
[TBL] [Abstract][Full Text] [Related]
38. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
[TBL] [Abstract][Full Text] [Related]
39. An ethyl acetate fraction of Artemisia capillaris (ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma.
Jung KH; Rumman M; Yan H; Cheon MJ; Choi JG; Jin X; Park S; Oh MS; Hong SS
Phytother Res; 2018 Oct; 32(10):2034-2046. PubMed ID: 29972254
[TBL] [Abstract][Full Text] [Related]
40. Tetramethylpyrazine Attenuates the Endotheliotoxicity and the Mitochondrial Dysfunction by Doxorubicin
Yang B; Li H; Qiao Y; Zhou Q; Chen S; Yin D; He H; He M
Oxid Med Cell Longev; 2019; 2019():5820415. PubMed ID: 31885804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
